Literature DB >> 12921332

Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance.

Bhava R J Kannan1, S Sivasankaran, Jaganmohan A Tharakan, Thomas Titus, V K Ajith Kumar, Bimal Francis, K M Krishnamoorthy, S Harikrishnan, R Padmakumar, Krishnakumar Nair.   

Abstract

BACKGROUND: There is a paucity of data regarding the long-term outcome of patients operated for ventricular septal defect with severe pulmonary arterial hypertension and elevated pulmonary vascular resistance. METHODS AND
RESULTS: We evaluated the long-term follow-up results of a selected cohort of patients with nonrestrictive ventricular septal defect and elevated pulmonary vascular resistance (>6 Wood units). Thirty-eight patients, median age 7.5 years (range 6 months-27 years), with nonrestrictive ventricular septal defect with severe pulmonary hypertension were operated between 1985 and 1996 at our institute. Preoperative pulmonary vascular resistance, ratio of pulmonary blood flow to systemic blood flow, and ratio of pulmonary vascular resistance to systemic vascular resistance were 7.63+/-1.8 Wood units, 1.9+/-0.48, and 0.41+/-0.12, respectively. The majority (68.4%) had perimembranous ventricular septal defect. Thirty patients (79%) had a good outcome and were asymptomatic at a mean follow-up of 8.7 years, with significant reduction in pulmonary artery pressures. Eight patients (21%) had a poor outcome, which included 5 immediate postoperative deaths, 1 late death and 2 surviving patients with persistent severe pulmonary arterial hypertension. There was no significant difference regarding hemodynamic parameters at baseline between those who had a good outcome and those who did not. Eleven patients with a preoperative pulmonary blood flow to systemic blood flow ratio of <2:1. who had a good outcome following surgery, underwent repeat catheterization at follow-up. There was a significant reduction in their mean pulmonary vascular resistance (8.03+/-1.4 v. 4.16+/-1.6 Wood units, p=0.001) and pulmonary vascular resistance to systemic vascular resistance ratio (0.41+/-0.12 v. 0.19+/-0.06, p=0.05).
CONCLUSIONS: The late results of surgery on this selected group of patients with nonrestrictive ventricular septal defect with high pulmonary vascular resistance are encouraging. Operative correction of the ventricular septal defect should be actively considered in all children presenting with nonrestrictive ventricular septal defect with a significant left-to-right shunt, despite moderately elevated pulmonary vascular resistance. Even among older patients with ventricular septal defect and moderately elevated pulmonary vascular resistance, there is a specific group that does well after operation.

Entities:  

Mesh:

Year:  2003        PMID: 12921332

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  13 in total

1.  Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension.

Authors:  Sachin Talwar; Shiv Kumar Choudhary; Sanket Garg; Anita Saxena; Sivasubramanian Ramakrishnan; Shyam Sunder Kothari; Rajnish Juneja; Balram Airan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-08

2.  EXPRESS: Parameters associated with outcome in pediatric patients with congenital heart disease and pulmonary hypertension subjected to combined vasodilator and surgical treatments.

Authors:  Ana Maria Thomaz; Luiz Junya Kajita; Vera D Aiello; Leína Zorzanelli; Filomena Rbg Galas; Cleide G Machado; Miguel Barbero-Marcial; Marcelo B Jatene; Marlene Rabinovitch; Antonio Augusto Lopes
Journal:  Pulm Circ       Date:  2019-02-26       Impact factor: 3.017

3.  Medical Therapies for Heart Failure in Hypoplastic Left Heart Syndrome.

Authors:  Angela N Baybayon-Grandgeorge; Ashley E Pietra; Shelley D Miyamoto; Anastacia M Garcia
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-12

4.  Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research Institute (PVRI).

Authors:  Antonio Augusto Lopes; Robyn J Barst; Sheila Glennis Haworth; Marlene Rabinovitch; Maha Al Dabbagh; Maria Jesus Del Cerro; Dunbar Ivy; Tarek Kashour; Krishna Kumar; S Harikrishnan; Michele D'Alto; Ana Maria Thomaz; Leína Zorzanelli; Vera D Aiello; Ana Olga Mocumbi; Maria Virginia T Santana; Ahmed Nasser Galal; Hanaa Banjar; Omar Tamimi; Alexandra Heath; Patricia C Flores; Gabriel Diaz; Julio Sandoval; Shyam Kothari; Shahin Moledina; Rilvani C Gonçalves; Alessandra C Barreto; Maria Angélica Binotto; Margarida Maia; Fahad Al Habshan; Ian Adatia
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

5.  Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces.

Authors:  Maria Jesus Del Cerro; Shahin Moledina; Sheila G Haworth; Dunbar Ivy; Maha Al Dabbagh; Hanaa Banjar; Gabriel Diaz; Alexandria Heath-Freudenthal; Ahmed Nasser Galal; Tilman Humpl; Snehal Kulkarni; Antonio Lopes; Ana Olga Mocumbi; G D Puri; Beyra Rossouw; S Harikrishnan; Anita Saxena; Patience Udo; Lina Caicedo; Omar Tamimi; Ian Adatia
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

6.  Pulmonary blood flow and pulmonary hypertension: Is the pulmonary circulation flowophobic or flowophilic?

Authors:  Thomas J Kulik
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

7.  Patients with congenital systemic-to-pulmonary shunts and increased pulmonary vascular resistance: what predicts postoperative survival?

Authors:  Hui-Li Gan; Jian-Qun Zhang; Qi-Wen Zhou; Lei Feng; Fei Chen; Yi Yang
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure.

Authors:  Jianqi Feng; Xiangqing Kong; Yanhui Sheng; Rong Yang
Journal:  Ther Clin Risk Manag       Date:  2016-11-03       Impact factor: 2.423

9.  Large patent ductus arteriosus: To close or not to close.

Authors:  Jaganmohan Tharakan; Subramanian Venkateshwaran
Journal:  Ann Pediatr Cardiol       Date:  2012-07

10.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease.

Authors:  Antonio Lopes; Khalid Alnajashi
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.